July 25, 2011 — Accuray Inc. announced the installation of the CyberKnife robotic radiosurgery system at five academic oncology centers in Europe and the United States, including the Penn Medicine at Pennsylvania Hospital in Philadelphia, Penn.; The Royal Marsden Hospital in London, England; The Barts Cancer Center at St. Bartholomew's Hospital in London, England; Charite University in Berlin, Germany; and Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice Branch in Gliwice, Poland.
Backed by solid clinical evidence for a wide range of treatment applications, including prostate and lung cancer, the CyberKnife system empowers these centers to offer minimally invasive radiosurgical treatment options for patients with even the most complex tumors.
"We chose the CyberKnife system because of the scientific evidence demonstrating the technology's ability to treat a broad range of tumors anywhere in the body. This functionality is simply not possible with other technologies, including hybrid radiation therapy systems," said Prof. Dr. Volker Budach and Prof. Dr. Peter Vajkoczy, respective heads of the departments of radiation oncology and neurosurgery at Charite University in Berlin. "Our mission at Charite is to provide patients with the most personalized care when treating cancer. The CyberKnife System, combined with our physicians' expertise, allows us to better tailor our treatments using the most advanced technology in radiosurgery."
For more information: www.accuray.com
September 11, 2026 
